Evidence-based medicine has proven safe and effective for the treatment of premature beats, paroxysmal atrial fibrillation, and bradyarrhythmia.
A drug for the treatment of arrhythmia with integrated regulation of multiple ion channels and non-ion channels.
Won the National Science and Technology Award
● "Shensong Yangxin Capsules Applied Research on Treatment of Arrhythmia" won the second prize of 2009 National Science and Technology Progress Award.
●"Construction of TCM Vein Theory and Its Guidance for Prevention and Treatment of Microvascular Diseases" won the first prize of 2019 National Science and Technology Progress Award.
Shensong Yangxin Capsules are recommended by multiple authoritative programs
"Guidelines for the Rational Use of Arrhythmia" (Second Edition)
"Atrial Fibrillation: Current Understanding and Treatment Recommendations-2018"